Skip to Content

Berry Genomics Co Ltd Class A 000710

Morningstar Rating
CNY 8.56 −0.35 (3.93%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

000710 is trading at a 823% premium.
Price
CNY 8.87
Fair Value
CNY 21.70
Uncertainty
Extreme
1-Star Price
CNY 61.73
5-Star Price
CNY 4.74
Economic Moat
Fbsmg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 000710 is a good fit for your portfolio.

Trading Information

Previous Close Price
CNY 8.91
Day Range
CNY 8.508.86
52-Week Range
CNY 5.4016.48
Bid/Ask
CNY 8.55 / CNY 8.56
Market Cap
CNY 3.03 Bil
Volume/Avg
12.9 Mil / 20.6 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.86
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Berry Genomics Co Ltd is an innovative biotechnology company. It providess gene sequencing detection equipment and services.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
1,438

Comparables

Valuation

Metric
000710
688253
688068
Price/Earnings (Normalized)
23.5313.75
Price/Book Value
1.682.810.84
Price/Sales
2.868.975.74
Price/Cash Flow
29.9913.5914.76
Price/Earnings
000710
688253
688068

Financial Strength

Metric
000710
688253
688068
Quick Ratio
1.6310.602.87
Current Ratio
2.0211.046.20
Interest Coverage
1,693.02
Quick Ratio
000710
688253
688068

Profitability

Metric
000710
688253
688068
Return on Assets (Normalized)
−13.01%4.47%−1.03%
Return on Equity (Normalized)
−18.59%4.81%−1.10%
Return on Invested Capital (Normalized)
−15.87%4.51%−1.96%
Return on Assets
000710
688253
688068
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRPnqssrkdfGgwz$598.1 Bil
VRTX
Vertex Pharmaceuticals IncNqvwgcdxwNrktm$115.5 Bil
REGN
Regeneron Pharmaceuticals IncFsbmltwmmKkqytw$109.5 Bil
MRNA
Moderna IncJysvthbTmqfj$54.0 Bil
BNTX
BioNTech SE ADRWcvvfrcvdDdpjg$24.7 Bil
ARGX
argenx SE ADRNcgxyygwPvkk$21.3 Bil
ALNY
Alnylam Pharmaceuticals IncJnqtmhpTpkcdg$19.1 Bil
BMRN
Biomarin Pharmaceutical IncMrbtscwHcfhsx$14.5 Bil
INCY
Incyte CorpXmqcbgfjPppnxpp$12.9 Bil
RPRX
Royalty Pharma PLC Class ARbfshzdwcvXvhgq$12.3 Bil

Sponsor Center